Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Wang

P2.03-26 a Prospective Cohort Study of TMB and Determinants of ctDNA Detection by Comprehensive Genomic Profiling in Stage I Lung Adenocarcinomas

Journal of Thoracic Oncology

English

MA25.07 Effectiveness of Systemic Therapy Combined With Thoracic Radiotherapy for Patients With Oligometastatic NSCLC: A Pooled Analysis

Journal of Thoracic Oncology

English

P1.09-40 Metastatic Endometrial Sarcoma Presenting as a Spontaneous Pneumothorax and Masquerading as a Pulmonary Blastoma

Journal of Thoracic Oncology

English

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P1.16-40 Evaluating the Tumor Heterogeneity in Lung Cancer by Constructing Tumor Heterogeneity Index (THI) From Magnetic Resonance Imaging

Journal of Thoracic Oncology

English

P1.01-95 Crizotinib Treatment in 29 Advanced NSCLC Chinese Patients With ROS1 Rearrangement——A Single Chinese Cancer Institute Experience

Journal of Thoracic Oncology

English

OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis From AURA17 Trial

Journal of Thoracic Oncology

English

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

Journal of Thoracic Oncology

English

32P Heterogeneity Study of Surgical Treatment Patterns Among 11 Medical Centers of China in 2013 – A Study of 2040 Patients Based on the Chinese National NSCLC Outcome Registry

Journal of Thoracic Oncology

English

P2.11-22 Use of Electronic Medical Records for Tobacco Use and Lung Cancer Screening Documentation in a Large Urban Academic Medicine Practice

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Wang

P2.03-26 a Prospective Cohort Study of TMB and Determinants of ctDNA Detection by Comprehensive Genomic Profiling in Stage I Lung Adenocarcinomas

MA25.07 Effectiveness of Systemic Therapy Combined With Thoracic Radiotherapy for Patients With Oligometastatic NSCLC: A Pooled Analysis

P1.09-40 Metastatic Endometrial Sarcoma Presenting as a Spontaneous Pneumothorax and Masquerading as a Pulmonary Blastoma

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

P1.16-40 Evaluating the Tumor Heterogeneity in Lung Cancer by Constructing Tumor Heterogeneity Index (THI) From Magnetic Resonance Imaging

P1.01-95 Crizotinib Treatment in 29 Advanced NSCLC Chinese Patients With ROS1 Rearrangement——A Single Chinese Cancer Institute Experience

OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis From AURA17 Trial

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

32P Heterogeneity Study of Surgical Treatment Patterns Among 11 Medical Centers of China in 2013 – A Study of 2040 Patients Based on the Chinese National NSCLC Outcome Registry

P2.11-22 Use of Electronic Medical Records for Tobacco Use and Lung Cancer Screening Documentation in a Large Urban Academic Medicine Practice